Davenport & Co’s Johnson & Johnson JNJ Stock Holding History

Davenport & Co’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Sell	7,400 -5,300	-42%	-$1.24M	0.01%	584
2026 Q1	$3.1M	Sell	12,700 -900	-7%	-$210K	0.02%	439
2025 Q4	$2.81M	Sell	13,600 -100	-0.7%	-$19.8K	0.02%	453
2025 Q3	$2.54M	Buy	13,700 +100	+0.7%	+$17.1K	0.01%	482
2025 Q2	$2.08M	Buy	13,600 +100	+0.7%	+$15.4K	0.01%	505
2025 Q1	$2.24M	Buy	13,500 +2,500	+23%	+$391K	0.01%	463
2024 Q4	$1.59M	Buy	11,000 +200	+2%	+$31K	0.01%	528
2024 Q3	$1.75M	Buy	10,800 +1,600	+17%	+$255K	0.01%	514
2024 Q2	$1.34M	Buy	9,200 +1,000	+12%	+$149K	0.01%	557
2024 Q1	$1.3M	Buy	8,200 +3,900	+91%	+$621K	0.01%	551
2023 Q4	$674K	Buy	4,300 +700	+19%	+$107K	﹤0.01%	685
2023 Q3	$561K	Buy	3,600 +1,800	+100%	+$297K	﹤0.01%	691
2023 Q2	$298K	Buy	+1,800	New	+$291K	﹤0.01%	889

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Davenport & Co's JNJ Position: Q2 2026 in Review

Davenport & Co reduced its Johnson & Johnson (JNJ) stake by 3.3% in Q2 2026, selling an estimated $6.94M and leaving 862,394 shares worth $220M. The position accounts for 1.08% of the portfolio, ranked #14.

Davenport & Co first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $326M in Q2 2022. 1,496 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Davenport & Co held 862,394 shares of Johnson & Johnson worth $220M as of Q2 2026.
Davenport & Co sold 29,793 Johnson & Johnson shares in Q2 2026, an estimated $6.94M.
Johnson & Johnson made up 1.08% of Davenport & Co's portfolio in Q2 2026, its #14 holding.
Davenport & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
Davenport & Co's Johnson & Johnson position peaked at $326M in Q2 2022.
1,496 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.